Axiota Animal Health

What Axiota Animal Health does

Axiota Animal Health is a privately held animal health company founded in 2020 and backed by Paine Schwartz Partners, formed through the combination of Multimin and MS Biotec to serve global beef and dairy cattle producers with two technology platforms. Its Multimin 90 product is the only FDA-approved (April 2024, NADA 141-582) injectable supplement delivering four trace minerals — zinc, copper, manganese, and selenium — in a single subcutaneous injection, achieving 100% bioavailability by bypassing rumen antagonists and reaching peak blood levels within 8-10 hours. Its Lactipro product line delivers Mega e, a proprietary rumen-native strain of Megasphaera elsdenii (NCIMB 41125) — of which Axiota and its affiliates are the world's only commercial providers — through three formulations (LactiproNXT drench, LactiproFLX capsule, LactiproEDGE feed additive) enabled by patented anaerobic fermentation and freeze-drying processes.

The company operates a dual-channel go-to-market model. Multimin 90 is sold on a prescription-only basis through licensed veterinarians, distributed via five major U.S. animal-health distributors (MWI Animal Health, Animal Health International, Midwest Veterinary Supply, Durvet, Covetrus). Lactipro is sold directly through a nationwide regional sales representative network and inside sales. Axiota serves four primary customer segments — cow/calf, backgrounder/stocker, feedlot, and dairy operations — with use cases spanning reproduction, transition-period health, vaccine response, and rumen development. The company holds four U.S. patents on Multimin 90 plus co-ownership of the Mega e bacterial strain patent, and its products have been used in 30+ countries and 30+ million head of cattle over the past 15 years. Operational footprint spans the Wamego, Kansas global headquarters (manufacturing, R&D, MS Biotec Microbial Technology Center) and the Warburton Technology Limited center in County Kerry, Ireland (trace mineral regulatory and IP), with a corporate mailing address in Fort Collins, Colorado.

Name

Axiota Animal Health

Legal name

Axiota Animal Health

Website

https://axiota.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Axiota Animal Health develops and markets FDA-approved injectable trace-mineral supplements (Multimin 90) and proprietary probiotic products (Lactipro with Mega e) for global beef and dairy cattle producers, selling through veterinary distributors and a direct sales force across 30+ countries.

Ownership category

akta.pro rank

Product category

Animal Health Supplements for Cattle

NAICS

Animal Food Manufacturing (3111), Other Animal Food Manufacturing (311119), Support Activities for Animal Production (11521)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH), Livestock & Poultry Nutrition (Feed & Premixes) (HLAMAHAD), Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO), Rumen-Protected & Bypass Nutrients (Protected Fats, Methionine/Lysine) (AFADAAAK)

Keywords

• Cattle health supplements
• Injectable trace minerals
• Rumen probiotic products
• Livestock nutritional supplements
• Animal health manufacturing

Headquarters

HQ city

Fort Collins

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Product Sales - Lactipro: Lactipro is sold in three formulations: LactiproNXT (low-volume drench), LactiproFLX (gelatin capsule), and LactiproEDGE (feed additive). Products are available for order through the Axiota website or via sales representatives. Lactipro has been used with confidence for more than 15 years in over 30 million head of cattle.
2. Product Sales - Multimin 90: Multimin 90 is a prescription-only product sold exclusively through licensed veterinarians and their distributor network. As the only FDA-approved injectable supplement delivering four trace minerals, it commands premium pricing through the veterinary channel.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Axiota Animal Health develops, manufactures, and markets prevention-focused, non-antibiotic animal health products for beef and dairy cattle producers. Its portfolio is built on two technology platforms: Multimin 90, an FDA-approved injectable supplement delivering four trace minerals (zinc, copper, manganese, selenium) with 100% bioavailability, and Lactipro, a probiotic family delivering rumen-native Mega e (Megasphaera elsdenii) bacteria to manage lactic acid and support rumen health in cattle.

Differentiator

Problem solved

Functional benefit

Brands

• Lactipro: Probiotic product delivering rumen-native, proprietary Mega e (Megasphaera elsdenii) — a targeted lactic acid utilizer. Available in three formulations: LactiproNXT (drench), LactiproFLX (capsule), and LactiproEDGE (feed additive).
• Multimin 90
• MS Biotec
• Warburton Technology

Products and services

• Multimin 90 Multimin 90 is the only FDA-approved injectable supplement delivering four trace minerals (zinc, copper, manganese, and selenium) in a single subcutaneous injection. It achieves peak blood levels within 8-10 hours and liver storage within 24 hours, with 100% bioavailability that bypasses rumen antagonists. It is a prescription-only product for licensed veterinarians and cattle operations, used to improve vaccine response, pregnancy rates, breeding soundness, and to reduce stillbirths, endometritis, and mastitis. Available in 500 mL packaging.

Quantifiable outcome

• Multimin 90 increases pregnancy rates by 17% in timed AI and up to 43% in timed embryo transfer
• +7 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Kansas State UniversitycoreStrategic or Co-development PartnerProximity to Kansas State University provides access to one of the nation's leading veterinary and animal health research institutions. The connection helps Axiota attract specialized scientific talent and collaborate with researchers advancing livestock health. Benefits the Wamego facility location decision.
• KC Animal Health CorridorcoreStrategic or Co-development PartnerThe KC Animal Health Corridor spans from Manhattan, Kansas to Columbia, Missouri with Kansas City at its heart. Home to over 300 animal health companies representing more than half of the global animal health industry's sales. Axiota's Wamego headquarters location leverages this animal health research hub.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Zinpro Corporation: Zinpro is the leading global manufacturer of trace minerals for livestock and poultry nutrition (Performance Minerals). It is the most direct competitor to Multimin 90, serving beef, dairy and other species with chelated mineral products sold through nutritional and veterinary channels.
• Phibro Animal Health Corporation: Phibro is a diversified animal health and nutrition company selling antibiotics, vaccines, mineral nutrition products, and feed additives for livestock (cattle, swine, poultry). Its livestock nutrition and production-animal therapeutic portfolio directly overlaps Axiota's cattle health focus.
• Lallemand Animal Nutrition: Lallemand is a leading developer and supplier of microbial-based feed additives (probiotics, yeast, bacteria) for ruminants and other livestock. Its rumen-specific probiotic products (including Megasphaera-containing offerings outside the U.S.) directly compete with Lactipro.
• Diamond V (Cargill Health Technologies): Diamond V (now part of Cargill) manufactures postbiotic and natural feed additives for ruminants focused on rumen health, immune function, and feed efficiency. Its direct-fed microbial and yeast-product portfolio overlaps with Lactipro in dairy and beef cattle.

Broad incumbents

• Chr. Hansen (now Novonesis): Novonesis (formed from Chr. Hansen and Novozymes) is a global bioscience company producing microbial cultures, probiotics, and enzymes for animal nutrition across multiple species. Its ruminant probiotic portfolio competes broadly with Lactipro at scale.
• Elanco Animal Health: Elanco is a global animal health leader offering pharmaceuticals, vaccines, and nutritional health products for livestock and pets. Its cattle health portfolio (including Rumensin and other rumen-active products) overlaps with both Multimin 90 and Lactipro.
• Zoetis: Zoetis is the world's largest animal health company, offering a comprehensive portfolio of medicines, vaccines, diagnostics, and nutritional products for livestock including beef and dairy cattle. Its broad portfolio makes it an incumbent competitor across most cattle health adjacencies where Axiota operates.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health business is a global leader in livestock vaccines, parasiticides, and pharmaceuticals for cattle, swine, and poultry. Its cattle portfolio and ruminant health programs overlap Axiota's positioning around transition cow health and herd productivity.

Emerging players

• Bio-Vet, Inc. Bio-Vet is a U.S.-based animal nutrition and direct-fed microbial company serving dairy, beef, and small ruminants with probiotic boluses, capsules, and feed additives. Its ruminant probiotic products (especially bolus/capsule formats) compete with Lactipro in the U.S. cow/calf and dairy segment.
• Vetoquinol: Vetoquinol is a global animal health pharmaceutical company offering prescription drugs, supplements, and nutrition products primarily for companion animals and livestock. Its U.S. livestock business provides a comparable mix of Rx and nutritional products distributed through veterinarians, similar to Multimin 90's channel model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/axiota

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries2 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axiota Animal Health